顺式-4-羟基环己烷羧酸, cis-4-Hydroxycyclohexanecarboxylic Acid

N-[3,5-双(三氟甲基)苯基]-N'-[(1S,2S)-2-[(11bR)-3,5-二氢-4H-联萘[2,1-c:1',2'-e]氮杂卓-4-基]环己基]脲, N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-[(11bR)-3,5

(S)-3-(((苄氧基)羰基)氨基)-4-甲基戊酸, (S)-3-(((Benzyloxy)carbonyl)amino)-4-methylpentanoic acid

1-溴-4-(异丙基磺酰基)苯, 1-Bromo-4-(isopropylsulfonyl)benzene

3-[[3,5-双(三氟甲基)苯基]氨基]-4-[[(8α,9S)-10,11-二氢-6'-甲氧基奎宁-9-基]氨基]-3-环丁-1,2-二酮, 3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(8α,9S)-10,11-

罗素伐他汀杂质C, Rosuvastatin EP Impurity C Sodium Salt

吡格列酮杂质B, Pioglitazone EP Impurity B

2-氨基-3-氰基-4-甲基吡啶, 2-Amino-4-methylnicotinonitrile

4,4,5,5-四甲基-2-(3-甲基吡啶-2-基)-1,3,2-二氧杂硼烷, 4,4,5,5-Tetramethyl-2-(3-methylthiophen-2-yl)-1,3,2-dioxabor

(S)-(2,2-二甲基-1,3-二氧戊环-4-基)甲胺, (S)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methanamine